Benitec Biopharma (BNTC) Return on Capital Employed (2020 - 2025)
Historic Return on Capital Employed for Benitec Biopharma (BNTC) over the last 6 years, with Q1 2025 value amounting to 0.44%.
- Benitec Biopharma's Return on Capital Employed rose 10200.0% to 0.44% in Q1 2025 from the same period last year, while for Mar 2025 it was 0.44%, marking a year-over-year increase of 10200.0%. This contributed to the annual value of 0.96% for FY2024, which is 144200.0% up from last year.
- As of Q1 2025, Benitec Biopharma's Return on Capital Employed stood at 0.44%, which was up 10200.0% from 0.37% recorded in Q4 2024.
- In the past 5 years, Benitec Biopharma's Return on Capital Employed registered a high of 0.37% during Q4 2024, and its lowest value of 8.07% during Q2 2023.
- Moreover, its 5-year median value for Return on Capital Employed was 1.29% (2021), whereas its average is 1.75%.
- In the last 5 years, Benitec Biopharma's Return on Capital Employed tumbled by -48200bps in 2023 and then surged by 72900bps in 2024.
- Over the past 5 years, Benitec Biopharma's Return on Capital Employed (Quarter) stood at 1.29% in 2021, then dropped by -14bps to 1.47% in 2022, then grew by 20bps to 1.18% in 2023, then soared by 68bps to 0.37% in 2024, then fell by -19bps to 0.44% in 2025.
- Its Return on Capital Employed stands at 0.44% for Q1 2025, versus 0.37% for Q4 2024 and 0.4% for Q3 2024.